Mirabig-S 25 Tablet ER is a once-daily, extended-release formulation that combines the muscarinic receptor antagonist, mirabegron (25mg), and the beta-3 adrenergic receptor agonist, solifenacin (5mg). This innovative medication is designed to treat symptoms of overactive bladder (OAB), including urinary frequency, urgency, and incontinence, as well as storage symptoms such as nocturia and hesitancy. Mirabig-S 25 Tablet ER works by relaxing the detrusor muscle and increasing bladder capacity, thereby reducing the frequency of urinary episodes. The medication's unique extended-release mechanism ensures consistent therapeutic levels throughout the day, providing prolonged symptom relief. This dual-action formulation allows for a balanced approach to managing OAB symptoms, minimizing the risk of anticholinergic side effects and preserving bladder function. As a convenient, once-daily treatment option, Mirabig-S 25 Tablet ER offers patients a reliable and effective solution for managing the daily challenges of overactive bladder.